RECENT NEWS
Aiosyn introduces kidney AI platform for renal disease research
AI-powered pathology solutions provider Aiosyn has announced the release of an AI kidney suite designed to advance research in the field of renal disease. Leveraging cutting-edge deep learning technology, this solution provides biopharma and research organisations with powerful tools for analysing kidney structures and quantifying lesions that impact kidney health.
Navigate BioPharma and BD to collaborate on developing flow cytometry
US-based laboratory Navigate BioPharma Services has announced a strategic collaboration with medical technology company BD (Becton, Dickinson and Company) to develop and commercialise flow cytometry-based companion diagnostics and tools for clinical decisions.
Agilent agrees sale of Resolution Bioscience to Exact Sciences
Agilent Technologies and Exact Sciences Corp, a leading provider of cancer screening and diagnostic tests, have announced they have entered into a definitive agreement for the sale of Resolution Bioscience to Exact Sciences.
Report reveals impact of COVID-19 research and innovation funding
A new independent report released by UKRI underscores the pivotal role played by UK researchers and innovators in tackling the pandemic.
ELRIG UK establishes engagement strategy work group
The European Laboratory Research & Innovation Group (ELRIG) UK has announced the formation of its Engagement Strategy Work Group (ESWG). The group will provide strategic direction and guidance to help ensure the ELRIG community continues to grow and thrive.
Giving clinicians critical information faster
Point-of-care (POC)-based blood gas analysers can support emergency department (ED) clinicians to make timely diagnoses to manage patient flow and ease overcrowding.
University of Limerick and Dell collaborate on predictive and diagnostic cancer research
Dell Technologies has joined forces with the University of Limerick's Digital Cancer Research Centre to develop an artificial intelligence (AI) platform and digital twin technology to power predictive and diagnostic research in oncology.
MRC innovation funding to tackle hard-to-treat cancers
The Medical Research Council (MRC) has announced a new £2 million investment supporting researchers to understand and treat cancers with exceptionally poor survival rates, including of the brain, lung and oesophagus. Four research innovation teams will each receive £500,000 to work across disciplines on high-risk, high-reward projects towards improving outcomes of hard-to-treat cancers.
Randox set to release eight new Quality Controls
Randox offers an extensive product offering comprising third-party quality controls and calibrators, interlaboratory data management, external quality assessment, calibration verification and molecular IQC and EQA for infectious disease testing. Randox Quality Control is now set to add eight Quality Controls to its range.
IBMS launches training grant programme
The Institute of Biomedical Science (IBMS) is launching a new grant to support the development of training solutions to support all staff working within biomedical science.
HORIBA celebrates anniversary at Congress with new haemostasis analysers
HORIBA UK will be marking its 70th anniversary at IBMS Congress later this month, where delegates are invited to join the celebrations and also to see the company’s newly launched fully automated haemostasis analysers.
Doris-Ann Williams steps down from BIVDA
Doris-Ann Williams has retired from her role as Chief Executive at BIVDA, after almost 22 years.
Paige and Microsoft to build the world’s largest image-based AI model to fight cancer
Digital pathology firm Paige has joined forces with Microsoft, with the two firms working to transform cancer diagnosis and patient care by building the world’s largest image-based artificial intelligence (AI) models for digital pathology and oncology.
UK rejoins Horizon Europe with a new bespoke deal
UK scientists will have access to the world’s largest research collaboration programme, Horizon Europe, after the Prime Minister Rishi Sunak secured a bespoke deal with improved financial terms for the UK’s participation.
Ibex raises $55 Million to drive global adoption of AI for cancer diagnosis
Ibex Medical Analytics (Ibex), which is innovating AI-powered cancer diagnostics, has announced it has closed a $55 million Series C financing round led by 83North. Additional participants in the round were Sienna Venture Capital and existing investors in the company, Octopus Ventures, aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital. The financing brings total funding to over $100 million since Ibex’s inception in 2016.
IBMS launches digital pathology white paper
The Institute of Biomedical Science (IBMS) has collaborated with Microsoft to publish a new white paper, ‘Digital Pathology and Integrated Care Systems: Enabling high-quality, equitable digital pathology services across networks, ICSs and nationally.’
BIOHIT HealthCare to present GastroPanel Quick Test at IBMS Congress
BIOHIT HealthCare will be attending IBMS Congress 2023, where the company will showcase its new GastroPanel Quick Test for triaging gastroscopy referrals.
Quest Diagnostics granted FDA breakthrough designation for AAV test
Quest Diagnostics has announced that its AAVrh74 ELISA (CDx) has been granted Breakthrough Device Designation from the US Food and Drug Administration (FDA).
NHS could benefit from single pathway for medical technology
Innovators seeking to bring their products to the NHS are still facing a lengthy and complex process, says the Medical Technology Group (MTG) in its latest 'Deja Review' report, with patients and clinicians missing out on the benefits provided by medical technology.
Scarborough Hospital pathology staff being relocated after RAAC discovered
Scarborough Hospital in North Yorkshire is the latest institute affected by aerated concrete, with pathology staff currently being relocated to other parts of the building.
Featured Supplier
As a world leader in the in-vitro diagnostics industry with over 35 years’ experience, Randox products offer clinicians and physicians the most comprehensive insight into patient diagnosis allowing for more effective disease management and treatment. Committed to improving health worldwide our diverse product portfolio currently comprises...
Upcoming Events
BIVDA Annual Regulatory Affairs Seminar
The Balmoral, 1 Princes Street, Edinburgh, EH2 2EQ
3-4 October 2023
Drug Discovery 2023
ACC Exhibition Centre, Liverpool
18-19 October
MEEGID XVI
Hilton Dresden, Germany
14-17 November 2023
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
